+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nutrigenomics Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon


  • 167 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5748716

Nutrigenomics is a fascinating, up-and-coming field that uses genetic testing to determine the interplay between genes, nutrition, and health

The Global Nutrigenomics Market is estimated to be USD 636.83 Mn in 2023 and is expected to reach USD 1382.56 Mn by 2028 growing at a CAGR of 16.77%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Nutrigenomics Market is segmented based on Product, Applications, and Geography.
  • By Product, the market is classified into Reagents & Kits, and Services.
  • By Applications, the market is classified into Cancer, Cardiovascular Diseases, and Obesity.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Genova Diagnostics, Gini Health Pvt. Ltd., Hologic, Inc., Koninklijke DSM N.V., Merck KGaA etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Nutrigenomics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Nutrigenomics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Nutrigenomics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Changing Lifestyle and Increase in Obese and Diabetic Population
4.1.2 Increasing Applications in Dermatology
4.1.3 Increase in Personalized Nutrition and Evaluation of Food Safety
4.2 Restraints
4.2.1 High Cost of Treatment
4.3 Opportunities
4.3.1 Increasing Applications in Dermatology
4.3.2 Advancements in Diagnostic Methods and Technology
4.4 Challenges
4.4.1 Lack of Proven Results for Nutrigenomics Study Support
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Nutrigenomics Market, By Product
6.1 Introduction
6.2 Reagents & Kits
6.3 Services
7 Global Nutrigenomics Market, By Applications
7.1 Introduction
7.2 Cancer
7.3 Cardiovascular Diseases
7.4 Obesity
8 Americas' Nutrigenomics Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Nutrigenomics Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Nutrigenomics Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Nutrigenomics Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 1health.io, Inc.
13.2 23andMe Inc.
13.3 BASF SE
13.4 Becton, Dickinson & Company
13.5 Danone Group
13.6 F. Hoffmann-La Roche Ltd.
13.7 GeneSmart Biotech Corp.
13.8 Genova Diagnostics
13.9 Gini Health Pvt. Ltd.
13.10 Hologic, Inc.
13.11 Koninklijke DSM N.V.
13.12 Merck KGaA
13.13 Metagenics
13.14 Nutrigenomix
13.15 PerkinElmer, Inc.
13.16 Polysciences, Inc.
13.17 QIAGEN GmbH
13.18 Sysmex Corp.
13.19 Takara Bio, Inc.
13.20 Thermo Fisher Scientific, Inc.
13.21 Unilever PLC
13.22 Xcode Life Sciences Pvt. Ltd.
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • 1health.io, Inc.
  • 23andMe Inc.
  • Becton, Dickinson & Company
  • Danone Group
  • F. Hoffmann-La Roche Ltd.
  • GeneSmart Biotech Corp.
  • Genova Diagnostics
  • Gini Health Pvt. Ltd.
  • Hologic, Inc.
  • Koninklijke DSM N.V.
  • Merck KGaA
  • Metagenics
  • Nutrigenomix
  • PerkinElmer, Inc.
  • Polysciences, Inc.
  • Sysmex Corp.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Unilever PLC
  • Xcode Life Sciences Pvt. Ltd.